4yog
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==HKU4-3CLpro bound to non-covalent inhibitor 3B== | ==HKU4-3CLpro bound to non-covalent inhibitor 3B== | ||
<StructureSection load='4yog' size='340' side='right' caption='[[4yog]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='4yog' size='340' side='right' caption='[[4yog]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4yog]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YOG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YOG FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4yog]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Bchk4 Bchk4]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YOG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YOG FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4F5:N-[4-(ACETYLAMINO)PHENYL]-2-(1H-BENZOTRIAZOL-1-YL)-N-[(1R)-2-(TERT-BUTYLAMINO)-2-OXO-1-(THIOPHEN-3-YL)ETHYL]ACETAMIDE'>4F5</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4F5:N-[4-(ACETYLAMINO)PHENYL]-2-(1H-BENZOTRIAZOL-1-YL)-N-[(1R)-2-(TERT-BUTYLAMINO)-2-OXO-1-(THIOPHEN-3-YL)ETHYL]ACETAMIDE'>4F5</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4yoi|4yoi]], [[4yo9|4yo9]], [[4yoj|4yoj]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4yoi|4yoi]], [[4yo9|4yo9]], [[4yoj|4yoj]]</td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yog FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yog OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4yog RCSB], [http://www.ebi.ac.uk/pdbsum/4yog PDBsum]</span></td></tr> | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">rep, 1a-1b ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=694007 BCHK4])</td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4yog FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4yog OCA], [http://pdbe.org/4yog PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4yog RCSB], [http://www.ebi.ac.uk/pdbsum/4yog PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4yog ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
Line 17: | Line 19: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4yog" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Bchk4]] | ||
[[Category: John, S E.St]] | [[Category: John, S E.St]] | ||
[[Category: Mesecar, A]] | [[Category: Mesecar, A]] | ||
[[Category: Hku4 3clpro mpro nsp5]] | [[Category: Hku4 3clpro mpro nsp5]] | ||
[[Category: Hydrolase-hydrolase inhibitor complex]] | [[Category: Hydrolase-hydrolase inhibitor complex]] |
Revision as of 15:53, 15 November 2017
HKU4-3CLpro bound to non-covalent inhibitor 3B
|